Osteoporosis is a condition characterized by weakened bones and an increased risk of fractures. One of the treatment strategies is to reduce bone resorption, which is the process where bone is broken down, and its minerals are released into the bloodstream.
Risedronate is the drug that decreases bone resorption in osteoporosis. It belongs to the class of medications called bisphosphonates, which work by inhibiting the bone-resorbing action of osteoclasts, cells that break down bone tissue.
Let's analyze the options:
- Teriparatide: Stimulates bone formation but does not primarily decrease resorption.
- Risedronate: Decreases bone resorption, therefore correct.
- Cortisone: A corticosteroid, which can actually increase bone resorption if used long-term.
- Cimetidine: An antihistamine, irrelevant to bone resorption.
Therefore, the correct choice is Risedronate, as it effectively decreases bone resorption, helping to manage osteoporosis.